激光胎盘血管消融术治疗严重双胎输血综合征后胎儿死亡、新生儿存活及神经发育结局的预测因素
该研究分析了2011至2022年间接受激光胎盘血管消融术(LAPV)的265例严重双胎羊水过少-过多序列(TOPS)病例,旨在识别胎儿死亡、新生儿存活及婴儿神经发育的预测因素。结果显示,供血儿术后死亡的预测因素为估计胎儿体重差值(p=0.045)和脐动脉舒张末期血流缺失或反向(AREDF-UA)(p<0.001);受血儿术后死亡的预测因素为水肿(p=0.009);新生儿存活的预测因素为出生孕周和Apgar评分;婴儿神经发育的预测因素在供血儿为经囟超声(TFUS)和LAPV前大脑中动脉多普勒(MCAD),在受血儿为LAPV前静脉导管血流和MCAD。
要点
- 供血儿LAPV后死亡的预测因素为估计胎儿体重差值和脐动脉舒张末期血流缺失或反向。
- 受血儿LAPV后死亡的预测因素为水肿。
- 新生儿存活预测因素为出生孕周和Apgar评分;神经发育预测因素因供血儿与受血儿而异。
核心结论
- 对于合并或不合并选择性胎儿生长受限(SFGR)和/或双胎贫血-红细胞增多序列(TAPS)的TOPS病例,在接受LAPV治疗后,可以预测胎儿死亡、新生儿存活及婴儿神经发育结局。
研究设计与样本
- 对2011年至2022年间接受LAPV治疗的病例进行分析,共纳入265例。
- 评估的产前预测变量包括TOPS分期、TAPS和/或SFGR的存在、LAPV前胎儿超声参数及围LAPV变量;围产期预测变量包括出生孕周、出生体重、Apgar评分和经囟超声(TFUS)。
- 采用二元逻辑回归分析检测结局预测因素。
主要发现
- 供血儿LAPV后死亡的预测因素为估计胎儿体重差值(p=0.045)和脐动脉舒张末期血流缺失或反向(p<0.001)。
- 受血儿LAPV后死亡的预测因素为水肿(p=0.009)。
- 新生儿存活的预测因素为出生孕周和Apgar评分。
- 供血儿神经发育的预测因素为TFUS和LAPV前大脑中动脉多普勒(MCAD)。
- 受血儿神经发育的预测因素为LAPV前静脉导管血流和MCAD。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To identify predictors of outcomes in severe twin oligo-polyhydramnios sequence (TOPS) with or without twin anemia-polycythemia sequence (TAPS) and/or selective fetal growth restriction (SFGR) treated by laser ablation of placental vessels (LAPV). METHODS: Analysis of cases treated from 2011 to 2022. Variables evaluated Prenatal predictors: stages of TOPS, presence of TAPS and/or SFGR; pre-LAPV fetal ultrasound parameters; peri-LAPV variables. Perinatal predictors: GA at birth; birthweight; Apgar scores; transfontanellar ultrasonography (TFUS). OUTCOME VARIABLES: fetal death, neonatal survival, infant's neurodevelopment. Binary logistic regression analyses were performed to detect predictors of outcomes. RESULTS: 265 cases were included. Predictors of post-LAPV donor fetus' death were delta EFW (p:0.045) and absent/reverse end-diastolic flow in the umbilical artery (AREDF-UA) (p < 0.001). The predictor of post-LAPV recipient fetus' death was hydrops (p:0.009). Predictors of neonatal survival were GA at birth and Apgar scores. Predictors of infant's neurodevelopment were TFUS and pre-LAPV middle cerebral artery Doppler (MCAD) for the donor twin; and pre-LAPV ductus venosus' flow and MCAD for the recipient twin. CONCLUSIONS: Prediction of fetal death, neonatal survival and infant's neurodevelopment is possible in cases of TOPS associated or not with SFGR and/or TAPS that were treated by LAPV.
引用
- Andrioli Peralta CF, Jorge Rodrigues da Costa K, Peneluppi Horak AC, et al. Predictors of fetal death, neonatal survival and neurological outcomes in severe twin-twin transfusion syndrome treated by laser ablation of placental vessels. Prenat Diagn. 2024. PMID: 38243614. doi:10.1002/pd.6523
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。